TGIF1 mRNA was markedly elevated in highly malignant gliomas compared to low‐grade counterparts; moreover, the expression of TGIF1 in recurrent gliomas was higher than that in primary gliomas. The gene discussed is TGIF1; the disease is central nervous system cancer.